In a mouse model of AD, LDLr demonstrated a beneficial effect via enhancement of Aβ clearance (Kim et al., 2009), suggesting its promising association with the risk for AD and consequently the involvement of PCSK9. The gene discussed is PCSK9; the disease is Alzheimer disease.